ProQR Therapeutics N.V. buy me8
Start price
22.02.22
/
0%
€1.03
Target price
22.02.23
€1.00
Performance (%)
-25.24%
End price
05.03.22
€0.77
Summary
This prediction ended on 05.03.22 with a price of €0.77. The prediction for ProQR Therapeutics N.V. disappointed with a performance of -25.24%. This prediction was marked as speculative and is excluded from me8's performance statistics.Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| ProQR Therapeutics N.V. | 6.286% | 6.286% | 7.526% |
| iShares Core DAX® | -1.042% | 2.220% | 14.279% |
| iShares Nasdaq 100 | -1.361% | 3.207% | 26.657% |
| iShares Nikkei 225® | -0.044% | -1.680% | 5.941% |
| iShares S&P 500 | -0.480% | 2.165% | 23.067% |
According to me8 what are the pros and cons of ProQR Therapeutics N.V. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Capable Management
Cons
Bad culture
Comments by me8 for this prediction
In the thread ProQR Therapeutics N.V. diskutieren
Buy ProQR Therapeutics N.V.
Kursziel gesetzt auf 1,0
In the thread Trading ProQR Therapeutics N.V.
Einschätzung wurde nach dem Ende von Catch the Monkey automatisch beendet.
Stopped prediction by me8 for ProQR Therapeutics N.V.
ProQR Therapeutics N.V.
Start price
Target price
Perf. (%)
€1.40
11.02.22
11.02.22
-
11.02.23
11.02.23
-25.71%
19.02.22
19.02.22
Could be worthwhile Investment >10% per year
Capable Management
Bad culture
